Clinical efficacy and pharmacoeconomics of a continuous-infusion piperacillin-tazobactam program in a large community teaching hospital

Pharmacotherapy

Volumn 22, Issue 4, 2002, Pages 471-483

  Grant, Edward M ^a,b   Kuti, Joseph L ^b   Nicolau, David P ^b   Nightingale, Charles ^b   Quintiliani, Richard ^b  

^a Ortho McNeil Pharmaceutical Incorporated   (United States)

^b HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PIPERACILLIN PLUS TAZOBACTAM;

ABDOMINAL INFECTION; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; COMMUNITY HOSPITAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG COST; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; ECONOMIC ASPECT; EDUCATION PROGRAM; FEMALE; HEALTH CARE COST; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGY; OUTCOMES RESEARCH; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SIDE EFFECT; SKIN INFECTION; SOFT TISSUE INFECTION; STATISTICAL ANALYSIS; TEACHING HOSPITAL;

AGED; AGED, 80 AND OVER; BACTERIAL INFECTIONS; CHI-SQUARE DISTRIBUTION; DRUG THERAPY, COMBINATION; FEMALE; HOSPITALS, COMMUNITY; HOSPITALS, TEACHING; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PENICILLANIC ACID; PIPERACILLIN; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 0036206559     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.22.7.471.33665     Document Type: Article

References (31)

1. Venoclysis
2. Penicillin as a chemotherapeutic agent
3. Bacteriostatic and lytic actions of penicillin on sensitive and resistant staphylococci
4. "Continuous" vs "discontinuous" therapy with penicillin: The effect of the interval between injections on therapeutic efficacy
5. Interrelationships between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins
6. Correlation of antimicrobial pharmacokinetic parameters with efficacy in an animal model
7. Optimal times above MICs of ceftibuten and cefaclor in experimental intra-abdominal infections
8. A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients
9. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media
10. Comparative dose-effect relations at several dosing intervals for β-lactam, aminoglycoside and quinolone antibiotics against gram-negative bacilli in murine thigh-infection and pneumonitis models
11. Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models
12. Therapeutic efficacy of continuous versus intermittent administration of ceftazidime in an experimental Klebsiella pneumoniae pneumonia in rats
13. Continuous infusion β-lactams: A pharmacodynamic approach
14. Antibiotic kinetics and dynamics for the clinician
15. Prediction of creatinine clearance from serum creatinine
16. Practice parameters for evaluating new fever in critically ill adult patients
17. Pharmacokinetic and economic evaluation of piperacillin-tazobactam administered as continuous or intermittent infusion with once-daily gentamicin
18. Pharmacoeconomic analysis of cefmenoxime dual individualization in the treatment of nosocomial pneumonia
19. Cost comparison of single daily doses of ceftriaxone versus continuous infusion of cefotaxime
20. Cost-effectiveness of ceftazidime by continuous infusion versus intermittent infusion for nosocomial pneumonia
21. Continuous vs intermittent infusion of cefuroxime for the treatment of community-acquired pneumonia
22. Cefuroxime by continuous infusion: A new standard of care?
23. Continuous infusion of ceftazidime in cystic fibrosis patients during home treatment: Clinical outcome, microbiology and pharmacokinetics
24. A pilot study of the efficacy of constant-infusion ceftazidime in the treatment of endobronchial infections in adults with cystic fibrosis
25. Pharmacokinetics of continuous and intermittent ceftazidime in intensive care unit patients with nosocomial pneumonia
26. Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia
27. Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis
28. Efficacy of continuous infusion of ceftazidime for patients with neutropenic fever after high-dose chemotherapy and peripheral blood stem cell transplantation
29. Influence of piperacillin-tazobactam on pharmacokinetics of gentamicin given once daily
30. Divergence in MIC distributions of Pseudomonas aeruginosa for piperacillin and piperacillin-tazobactam
31. Pharmacodynamic profile of continuously infused piperacillin-tazobactam against Pseudomonas aeruginosa using Monte Carlo analysis